|
EMA Completes Probe Into Production Processes At Baxter's Manufacturing Plant - Fox Business |
Fox Business
-This follows the detection in December 2010 of endotoxins in dialysis solutions produced at the plant, which may have led to adverse reactions in some patients undergoing peritoneal dialysis. -The products affected include Dianeal, Extraneal and
|
|
$5M gift to hospital repays 'debt' - Ottawa Citizen |
Ottawa Citizen
The new wing will house expanded and enhanced ambulatory care facilities, 10 new state-of-theart operating suites and a new dialysis service with 15 stations. Tom Schonberg, the Queensway-Carleton's president and CEO, said the hospital was "thrilled
|
VEGF inhibitors in metastatic renal cell carcinoma: Current therapies and ... - UroToday |
UroToday
Metastatic renal cell carcinoma (RCC) is predominantly refractory to treatment with traditional cytotoxic chemotherapies, and until recently management options were limited to immunotherapy, palliative care, or phase I trials.
|
Pedal Power To Help Dialysis Patients - WIBW |
WIBW
(WIBW) - For a third year, the two men at the helm of Kansas Dialysis Services are using pedal power to push their patients to better health. Medical Director Dr. Scott Solcher and CEO Stan Langhofer embark on their 3rd annual "Tour de Dialysis" Sept.
|
DaVita Breaking Down? - TradersHuddle.com |
TradersHuddle.com
DaVita, Inc. (NYSE:DVA) provides dialysis services for patients suffering from chronic kidney failure. The Company treats patients through a network of owned and managed dialysis facilities in the continental United States. DaVita's stock was trading
|
|
|
|
<< Start < Prev 681 682 683 684 685 686 687 688 689 690 Next > End >>
|
Page 684 of 2630 |